In one BC study, mutated PI3K-AKT pathways were detected among 29.8% TNBC patients, and over 70% of these patients carried PIK3CA mutations, which was consistent with our findings in this study including 4 BC subtypes (40). Here, PIK3CA is linked to breast cancer.